Announced
Synopsis
Hitachi High-Tech, a trading company handling a variety of products, agreed to invest in Invivoscribe, a developer of medical diagnostic tools. Financial terms were not disclosed. "Hitachi High-Tech has been strengthening its molecular diagnosis business centered on genetic testing. By combining Invivoscribe’s testing service business with our experiences gained from the equipment business, we aim to build a unique business model and provide a wide range of services to medical professionals," Yoshimitsu Takagi, Hitachi High-Tech Vice President, Executive Officer and General Manager.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.